These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2045166)

  • 1. Insulin resistance and blood pressure regulation in obese and nonobese subjects. Special lecture.
    Rocchini AP
    Hypertension; 1991 Jun; 17(6 Pt 2):837-42. PubMed ID: 2045166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic factors determine the blood pressure response to insulin resistance and hyperinsulinemia: a call to refocus the insulin hypothesis of hypertension.
    Mark AL; Anderson EA
    Proc Soc Exp Biol Med; 1995 Apr; 208(4):330-6. PubMed ID: 7700882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, energy balance and sympathetic nervous system activity.
    Landsberg L
    Clin Exp Hypertens A; 1990; 12(5):817-30. PubMed ID: 2208753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.
    Westerbacka J; Vehkavaara S; Bergholm R; Wilkinson I; Cockcroft J; Yki-Järvinen H
    Diabetes; 1999 Apr; 48(4):821-7. PubMed ID: 10102699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR).
    Ferrannini E; Natali A; Capaldo B; Lehtovirta M; Jacob S; Yki-Järvinen H
    Hypertension; 1997 Nov; 30(5):1144-9. PubMed ID: 9369268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.
    Mioni R; Cà AD; Turra J; Azzolini S; Xamin N; Bleve L; Maffei P; Vettor R; Fallo F
    Endocrine; 2017 Feb; 55(2):625-634. PubMed ID: 27142411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin and blood pressure: possible role of hemodynamics.
    Ferrannini E
    Clin Exp Hypertens A; 1992; 14(1-2):271-84. PubMed ID: 1541041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperinsulinism, heart rate variability and circadian variation of arterial pressure in obese hypertensive patients].
    Galinier M; Fourcade J; Ley N; Boveda S; Solera S; Solera ML; Massabuau P; Elhabaj S; Fauvel JM; Valdiguié P; Bounhoure JP
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1105-9. PubMed ID: 10486674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms.
    Hall JE; Brands MW; Hildebrandt DA; Mizelle HL
    Hypertension; 1992 Jan; 19(1 Suppl):I45-55. PubMed ID: 1730454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
    Mori Y; Tanaka T; Matsuura K; Yokoyama J; Utsunomiya K
    Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].
    Greco D; Sinagra D
    G Ital Cardiol; 1995 Feb; 25(2):207-16. PubMed ID: 7642026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure, insulin secretion and resistance in nonhypertensive and hypertensive obese female subjects.
    Sinagra D; Greco D; Scarpitta AM; Bonaventura V
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):610-3. PubMed ID: 8574270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, obesity and hypertension.
    Rocchini AP
    J Nutr; 1995 Jun; 125(6 Suppl):1718S-1724S. PubMed ID: 7782934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?
    Brun JF; Aloulou I; Varlet-Marie E
    Clin Hemorheol Microcirc; 2004; 30(3-4):203-9. PubMed ID: 15258344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium and obesity in the pathogenesis of hypertension.
    Reisin E
    Am J Hypertens; 1990 Feb; 3(2):164-7. PubMed ID: 2155002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance--not hyperinsulinemia--is pathogenic in essential hypertension.
    McCarty MF
    Med Hypotheses; 1994 Apr; 42(4):226-36. PubMed ID: 8072428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinemia: a link between obesity and hypertension?
    Hall JE
    Kidney Int; 1993 Jun; 43(6):1402-17. PubMed ID: 8315956
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin resistance and hypertension.
    Hsueh WA
    Am J Nephrol; 1991; 11(4):265-70. PubMed ID: 1799182
    [No Abstract]   [Full Text] [Related]  

  • 20. [Obese children with benign acanthosis nigricans and insulin resistance: analysis of 19 cases].
    Fu JF; Liang L; Dong GP; Jiang YJ; Zou CC
    Zhonghua Er Ke Za Zhi; 2004 Dec; 42(12):917-9. PubMed ID: 15733362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.